Exosome-Based Theranostics for Liver Diseases.

Authors:
Luo N; Li J; Dong R; Lu J.

Journal:
Dis Markers

Publication Year: 2022

DOI:
10.1155/2022/7888906

PMCID:
PMC9646311

PMID:
36393973

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Dis Markers

Abbreviation: Dis Markers

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.
Igder S; Zamani M; Fakher S and 4 more (2024) - Transparency Score: 3/6
Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Distinguishing Lung Cancer in People with H…
Baluku JB; Namiiro S; Namanda B and 7 more (2024) - Transparency Score: 3/6
Arterial Hypertension and Its Consequences Are the Main Predictors of Embolic Stroke of Undetermine…
Berdalin AB; Namestnikova DD; Cherkashova EA and 3 more (2023) - Transparency Score: 4/6
Association between Serum Cys C and PTB Cavitation.
Tan S; Wu D; Wu Y and 3 more (2023) - Transparency Score: 3/6
Characterization of TIM-3 Expression and Its Correlation with TNF-<i>α</i> and IFN-<i>γ</i> in Pati…
Tan J; Shen P; Yang X and 2 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare no conflict of interest."

Evidence found in paper:

"This work was supported by the Social Development Grant of Shaanxi Province [2020SF-067] and Innovative Development Fund of Tangdu Hospital [XJSXYW2021136]."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025